Cargando…
Lung cancer screening: who pays? Who receives? The European perspectives
Lung cancer is the leading cause of cancer-related death worldwide, and its early detection is critical to achieving a curative treatment and to reducing mortality. Low-dose computed tomography (LDCT) is a highly sensitive technique for detecting noninvasive small lung tumors in high-risk population...
Autores principales: | Novellis, Pierluigi, Cominesi, Silvia Raimondi, Rossetti, Francesca, Mondoni, Michele, Gregorc, Vanesa, Veronesi, Giulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182705/ https://www.ncbi.nlm.nih.gov/pubmed/34164287 http://dx.doi.org/10.21037/tlcr-20-677 |
Ejemplares similares
-
Lung cancer screening: who pays? who receives?—the Chinese perspective
por: Zhang, Yang, et al.
Publicado: (2021) -
Cervical cancer testing among women aged 30–49 years in the WHO European Region
por: Williams, Julianne, et al.
Publicado: (2021) -
Managing of screening-detected sub-solid nodules—a European perspective
por: Ricciardi, Sara, et al.
Publicado: (2021) -
Initial results of the National Lung Cancer Screening Trial
por: McLoud, T.C.
Publicado: (2011) -
NELSON lung cancer screening study
por: Zhao, Ying Ru, et al.
Publicado: (2011)